Cite
Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.
MLA
Han, Lyrialle W., et al. “Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.” Journal of Clinical Pharmacology, vol. 59, no. 12, Dec. 2019, pp. 1678–89. EBSCOhost, https://doi.org/10.1002/jcph.1477.
APA
Han, L. W., Ryu, R. J., Cusumano, M., Easterling, T. R., Phillips, B. R., Risler, L. J., Shen, D. D., & Hebert, M. F. (2019). Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy. Journal of Clinical Pharmacology, 59(12), 1678–1689. https://doi.org/10.1002/jcph.1477
Chicago
Han, Lyrialle W, Rachel J Ryu, Michael Cusumano, Thomas R Easterling, Brian R Phillips, Linda J Risler, Danny D Shen, and Mary F Hebert. 2019. “Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.” Journal of Clinical Pharmacology 59 (12): 1678–89. doi:10.1002/jcph.1477.